Clinical Trial: Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07426107) titled 'Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization' on Dec. 17, 2025.

Brief Summary: This study employs a dual-cohort design to develop and validate a prognostic model for Major Adverse Cardiovascular Events (MACE) following revascularization in immune thrombocytopenia (ITP) patients with Coronary Artery Disease (CAD). The model will be developed and trained using a retrospective multi-center cohort (development/training cohort). Its performance will then be prospectively validated in a separate, consecutively enrolled prospective cohort (validation cohort). The ...